Celldex Therapeutics (CLDX) Other Non-Current Assets (2010 - 2026)
Celldex Therapeutics' Other Non-Current Assets came in at $15.43 million for Q2 2026, up 66.0% from $9.3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Other Non-Current Assets was $13.36 million, up 37.0% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 218.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $9.75 million in FY2024, $107,000 in FY2023 (+2.9%), $104,000 in FY2022 (unchanged) and $104,000 in FY2021 (+153.7%).
- Year-over-year, Other Non-Current Assets has increased for three consecutive quarters, with growth averaging 36.8% over the last four quarters.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q2 2022 (growth of 153.7%), and the weakest in Q3 2025 (a decline of 3.9%).
- Business Quant data shows CLDX's Other Non-Current Assets at $15.43 million (Q1 2026), $13.36 million (Q4 2025) and $9.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Celldex Therapeutics | 2.54 Bn | 2.54 Bn | - | 15.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.43 Mn |
| Mar 31, 2026 | 15.43 Mn |
| Dec 31, 2025 | 13.36 Mn |
| Sep 30, 2025 | 9.36 Mn |
| Jun 30, 2025 | 9.30 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Dec 31, 2024 | 9.75 Mn |
| Sep 30, 2024 | 9.75 Mn |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 107,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Sep 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | 104,000.00 |
| Sep 30, 2022 | 104,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 98,000.00 |
API Access
Celldex Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();